BillTrack50 logo
Free Signup Login
Bill

Bill > HB729

KY HB729

KY HB729
AN ACT relating to pharmaceutical drug safety and declaring an emergency.

summary

Introduced
02/25/2026
In Committee
03/04/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

Amend KRS 315.010 to define terms; amend KRS 315.020 to require a terminal distributor to designate a responsible practitioner for each permitted location; require the Kentucky Board of Pharmacy to promulgate administrative regulations to establish criteria for a responsible practitioner; permit the board to enter agreements with other states, federal agencies, and entities to exchange information concerning permitting and inspection of pharmacies and terminal distributors; amend KRS 315.035 and 315.0351 to update the name of an approved accreditation agency to National Association of Boards of Pharmacy Digital Pharmacy Accreditation Program; permit the board to consider previous permit compliance and violations of permit applicants; amend KRS 315.121 to require the board to retain jurisdiction to investigate and to take disciplinary action for acts or omissions committed while a person was licensed, permitted, or certified even if the person is no longer licensed, permitted, or certified; amend KRS 315.131 to permit the board to extend temporary emergency suspensions of a license, certificate, or permit for 60 to 180 days; amend KRS 315.191 to prohibit the board from regulating other professions; amend KRS 315.220 to permit the board to enter all licensed or permitted facilities and any facility suspected of operating as a pharmacy, terminal distributor, wholesaler, or manufacturer; establish inspection criteria; permit the board to investigate any location at which it has reasonable cause to suspect a violation is being committed; require cooperation with investigations; create new sections of KRS Chapter 315 to require that on or after January 1, 2027, a permit is required to operate as a terminal distributor of prescription drugs; establish permit requirements for terminal distributors; establish requirements for internet business; allow the board to consider previous permit compliance and violations of permit applicants; allow temporary permit transfer; establish permit exclusions; require the board to promulgate administrative regulations to implement the permit process; establish compounding requirements and prohibitions; require reporting of a serious adverse event to the board within 5 business days; require the board to report violations and inspections to a responsible practitioners' licensing board; require the board to submit a report to the Legislative Research Commission on its inspection and investigation findings by August 1 of each year; permit the board to take action to restrain or enjoin; amend KRS 315.990 to add penalties; amend KRS 194A.800, 217.215, 217.913, and 315.205 to conform; provide that the Act may be cited as Jimmie's Law; EMERGENCY.

AI Summary

This bill, known as Jimmie's Law, aims to enhance pharmaceutical drug safety in Kentucky by updating regulations for pharmacies and drug distributors. Key provisions include requiring terminal distributors of prescription drugs to designate a responsible practitioner, who will share responsibility for the location's operations with the distributor, and empowering the Kentucky Board of Pharmacy (the Board) to establish criteria for these practitioners. The bill also allows the Board to enter into agreements with other states and federal agencies to exchange information on pharmacy and distributor permitting and inspections, and to consider an applicant's past compliance and violations when reviewing permit applications. It updates the name of an approved accreditation agency to the National Association of Boards of Pharmacy (NABP) Digital Pharmacy Accreditation Program and clarifies that the Board retains jurisdiction to investigate and take disciplinary action even if a person is no longer licensed or permitted. The Board's authority to extend temporary emergency suspensions of licenses or permits is increased, and it is explicitly prohibited from regulating other professions. Furthermore, the bill grants the Board broader inspection powers, allowing them to enter any licensed or permitted facility, as well as any facility suspected of operating as a pharmacy or drug distributor, and to investigate locations where violations are suspected, requiring cooperation from those involved. Crucially, starting January 1, 2027, a permit will be required to operate as a terminal distributor of prescription drugs, with specific requirements for internet businesses, temporary permit transfers, and permit exclusions. The bill also establishes compounding requirements and prohibitions, mandates reporting of serious adverse events to the Board within five business days, requires the Board to report violations and inspections to responsible practitioners' licensing boards, and mandates an annual report to the Legislative Research Commission on inspection and investigation findings. Penalties for violations are also updated, and the bill includes conforming amendments to other related statutes, declaring an emergency to ensure its immediate effectiveness.

Committee Categories

Labor and Employment

Sponsors (3)

Last Action

to Licensing, Occupations, & Administrative Regulations (H) (on 03/04/2026)

bill text

bill summary

Loading...

bill summary

Loading...
Loading...